REATA PHARMACEUTICALS INC Depreciation in USD from 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Reata Pharmaceuticals Inc quarterly/annual Depreciation history and growth rate from 2015 to Q2 2023.
  • Reata Pharmaceuticals Inc Depreciation for the quarter ending June 30, 2023 was $293K, a 7.33% increase year-over-year.
  • Reata Pharmaceuticals Inc Depreciation for the twelve months ending June 30, 2023 was $1.13M, a 7.6% decline year-over-year.
  • Reata Pharmaceuticals Inc annual Depreciation for 2022 was $1.13M, a 6.07% decline from 2021.
  • Reata Pharmaceuticals Inc annual Depreciation for 2021 was $1.2M, a 5.9% increase from 2020.
  • Reata Pharmaceuticals Inc annual Depreciation for 2020 was $1.14M, a 21.9% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

REATA PHARMACEUTICALS INC Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.13M $293K +$20K +7.33% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.11M $288K -$20K -6.49% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.13M $277K -$45K -14% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-24
Q3 2022 $1.18M $272K -$48K -15% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.22M $273K -$14K -4.88% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $1.24M $308K +$34K +12.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.2M $322K +$37K +13% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 $1.17M $320K +$31K +10.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.14M $287K +$3K +1.06% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.13M $274K -$4K -1.44% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $1.14M $285K +$13K +4.78% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $1.12M $289K +$31K +12% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.09M $284K +$52K +22.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $1.04M $278K +$108K +63.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $932K $272K +$152K +127% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $780K $258K +$153K +146% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $627K $232K +$127K +121% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $500K $170K +$69K +68.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $431K $120K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $105K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $105K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $101K -$29K -22.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $130K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08

REATA PHARMACEUTICALS INC Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.13M -$73K -6.07% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 $1.2M +$67K +5.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 $1.14M +$204K +21.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $932K +$501K +116% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $431K -$6K -1.37% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $437K -$245K -35.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $682K -$1.14M -62.5% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $1.82M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.